Your browser doesn't support javascript.
loading
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng, Kun-Yu; Han, Jianfeng; Zhang, Xiaoli; Hsu, Shu-Hao; He, Shun; Wani, Nissar A; Barajas, Juan M; Snyder, Linda A; Frankel, Wendy L; Caligiuri, Michael A; Jacob, Samson T; Yu, Jianhua; Ghoshal, Kalpana.
Afiliación
  • Teng KY; Molecular, Cellular and Developmental Biology Program, The Ohio State University, Columbus, Ohio.
  • Han J; Department of Pathology, The Ohio State University, Columbus, Ohio.
  • Zhang X; Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
  • Hsu SH; Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
  • He S; Center for Biostatistics, The Ohio State University, Columbus, Ohio.
  • Wani NA; Department of Pathology, The Ohio State University, Columbus, Ohio.
  • Barajas JM; Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
  • Snyder LA; Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
  • Frankel WL; Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio.
  • Caligiuri MA; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Jacob ST; Department of Pathology, The Ohio State University, Columbus, Ohio.
  • Yu J; Comprehensive Cancer Center, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
  • Ghoshal K; Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio.
Mol Cancer Ther ; 16(2): 312-322, 2017 02.
Article en En | MEDLINE | ID: mdl-27980102

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Carcinoma Hepatocelular / Quimiocina CCL2 / Receptores CCR2 / Neoplasias Hepáticas / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Carcinoma Hepatocelular / Quimiocina CCL2 / Receptores CCR2 / Neoplasias Hepáticas / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2017 Tipo del documento: Article